• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过相对单倍型剂量对杜氏和贝克型肌营养不良症进行无创产前诊断。

Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage.

作者信息

Parks Michael, Court Samantha, Cleary Siobhan, Clokie Samuel, Hewitt Julie, Williams Denise, Cole Trevor, MacDonald Fiona, Griffiths Mike, Allen Stephanie

机构信息

West Midlands Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.

出版信息

Prenat Diagn. 2016 Apr;36(4):312-20. doi: 10.1002/pd.4781. Epub 2016 Feb 23.

DOI:10.1002/pd.4781
PMID:26824862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4864947/
Abstract

OBJECTIVE

Development of an accurate and affordable test for the non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies (DMD/BMD) to implement in clinical practice.

METHOD

Cell-free DNA was extracted from maternal blood and prepared for massively parallel sequencing on an Illumina MiSeq by targeted capture enrichment of single nucleotide polymorphisms (SNPs) across the dystrophin gene on chromosome X. Sequencing data were analysed by relative haplotype dosage.

RESULTS

Seven healthy pregnant donors and two pregnant DMD carriers all bearing a male fetus were recruited through the non-invasive prenatal diagnosis for single gene disorders study. Non-invasive prenatal diagnosis testing was conducted by relative haplotype dosage analysis for X-linked disorders where the genomic DNA from the chorionic villus sampling (for healthy pregnant donors) or from the proband (for pregnant DMD carriers) was used to identify the reference haplotype. Results for all patients showed a test accuracy of 100%, when the calculated fetal fraction was >4% and correlated with known outcomes. A recombination event was also detected in a DMD patient.

CONCLUSION

Our new test for NIPD of DMD/BMD has been shown to be accurate and reliable during initial stages of validation. It is also feasible for implementation into clinical service.

摘要

目的

开发一种准确且经济实惠的检测方法,用于杜氏和贝克型肌营养不良症(DMD/BMD)的无创产前诊断,以便在临床实践中应用。

方法

从母血中提取游离DNA,并通过对X染色体上肌营养不良蛋白基因的单核苷酸多态性(SNP)进行靶向捕获富集,为在Illumina MiSeq上进行大规模平行测序做准备。测序数据通过相对单倍型剂量进行分析。

结果

通过单基因疾病的无创产前诊断研究招募了7名健康的怀孕捐赠者和2名怀有男性胎儿的怀孕DMD携带者。对于X连锁疾病,通过相对单倍型剂量分析进行无创产前诊断检测,其中来自绒毛取样(针对健康怀孕捐赠者)或先证者(针对怀孕DMD携带者)的基因组DNA用于确定参考单倍型。当计算出的胎儿游离DNA比例>4%且与已知结果相关时,所有患者的检测准确率均为100%。在一名DMD患者中还检测到了一次重组事件。

结论

我们新的DMD/BMD无创产前诊断检测方法在验证的初始阶段已被证明准确可靠。将其应用于临床服务也是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/f5f3aac13352/PD-36-312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/3a744bff3556/PD-36-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/1152654e9634/PD-36-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/3315551f05d1/PD-36-312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/f5f3aac13352/PD-36-312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/3a744bff3556/PD-36-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/1152654e9634/PD-36-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/3315551f05d1/PD-36-312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/109f/4864947/f5f3aac13352/PD-36-312-g004.jpg

相似文献

1
Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage.通过相对单倍型剂量对杜氏和贝克型肌营养不良症进行无创产前诊断。
Prenat Diagn. 2016 Apr;36(4):312-20. doi: 10.1002/pd.4781. Epub 2016 Feb 23.
2
Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage.通过相对单倍型剂量进行脊髓性肌萎缩症的无创产前诊断。
Eur J Hum Genet. 2017 Apr;25(4):416-422. doi: 10.1038/ejhg.2016.195. Epub 2017 Jan 25.
3
Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma.基于单倍型的方法,利用孕妇血浆中的游离胎儿DNA进行杜氏肌营养不良症的无创产前检测。
Genet Med. 2015 Nov;17(11):889-96. doi: 10.1038/gim.2014.207. Epub 2015 Feb 5.
4
Targeted linked-read sequencing for direct haplotype phasing of maternal DMD alleles: a practical and reliable method for noninvasive prenatal diagnosis.靶向连接读取测序技术用于母源 DMD 等位基因的直接单体型定相:一种实用且可靠的无创性产前诊断方法。
Sci Rep. 2018 Jun 6;8(1):8678. doi: 10.1038/s41598-018-26941-0.
5
Noninvasive prenatal diagnosis of duchenne muscular dystrophy: comprehensive genetic diagnosis in carrier, proband, and fetus.无创性产前诊断杜氏肌营养不良症:携带者、先证者和胎儿的全面基因诊断。
Clin Chem. 2015 Jun;61(6):829-37. doi: 10.1373/clinchem.2014.236380. Epub 2015 Apr 6.
6
Haplotype-Based noninvasive prenatal diagnosis for duchenne muscular dystrophy: A pilot study in South China.基于单体型的无创性产前诊断杜氏肌营养不良症:华南地区的一项初步研究。
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:15-22. doi: 10.1016/j.ejogrb.2019.05.005. Epub 2019 May 8.
7
Noninvasive prenatal diagnosis for Duchenne muscular dystrophy based on the direct haplotype phasing.基于直接单体型定相的杜氏肌营养不良症的无创性产前诊断。
Prenat Diagn. 2020 Jul;40(8):918-924. doi: 10.1002/pd.5641. Epub 2020 Jun 4.
8
Exploring factors impacting haplotype-based noninvasive prenatal diagnosis for single-gene recessive disorders.探索影响单基因隐性疾病基于单倍型的无创产前诊断的因素。
Clin Genet. 2024 Jan;105(1):52-61. doi: 10.1111/cge.14434. Epub 2023 Oct 11.
9
Prenatal diagnosis of Duchenne muscular dystrophy revealed a novel mosaic mutation in Dystrophin gene: a case report.产前诊断出杜氏肌营养不良症,发现肌营养不良蛋白基因的一种新型镶嵌突变:一例报告。
BMC Med Genet. 2020 Nov 11;21(1):222. doi: 10.1186/s12881-020-01157-0.
10
Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.62 个中国杜氏肌营养不良症家系的遗传学分析及单中心产前诊断策略。
BMC Med Genet. 2019 Nov 14;20(1):180. doi: 10.1186/s12881-019-0912-x.

引用本文的文献

1
Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons.杜氏肌营养不良症:将当前临床实践与未来治疗及诊断前景相结合
Int J Mol Sci. 2025 Jul 14;26(14):6742. doi: 10.3390/ijms26146742.
2
Non-Invasive Determination of the Paternal Inheritance in Pregnancies at Risk for β-Thalassaemia by Analyzing Cell-Free Fetal DNA Using Targeted Next-Generation Sequencing.通过靶向新一代测序分析游离胎儿DNA对β地中海贫血高危妊娠中父系遗传进行无创性测定。
Int J Mol Sci. 2025 Jan 10;26(2):570. doi: 10.3390/ijms26020570.
3
Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.

本文引用的文献

1
Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach.软骨发育不全和致死性骨发育不良的非侵入性产前诊断:新一代测序提供了一种更安全、更准确且更全面的方法。
Prenat Diagn. 2015 Jul;35(7):656-62. doi: 10.1002/pd.4583. Epub 2015 May 26.
2
Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis.囊性纤维化的非侵入性产前诊断:父系突变检测、患者偏好探索及成本分析。
Prenat Diagn. 2015 Oct;35(10):950-8. doi: 10.1002/pd.4585. Epub 2015 Apr 5.
3
非侵入性产前诊断(NIPD):当前技术与新兴技术
Extracell Vesicles Circ Nucl Acids. 2023 Feb 22;4(1):3-26. doi: 10.20517/evcna.2022.44. eCollection 2023.
4
Non-invasive prenatal detection of dominant single-gene disorders in fetal structural abnormalities: a clinical feasibility study.胎儿结构异常中显性单基因疾病的非侵入性产前检测:一项临床可行性研究。
Arch Gynecol Obstet. 2024 Dec;310(6):2943-2955. doi: 10.1007/s00404-024-07800-y. Epub 2024 Nov 16.
5
Clinical Potential of Expanded Noninvasive Prenatal Testing for Detection of Aneuploidies and Microdeletion/Microduplication Syndromes.扩展无创产前检测在检测非整倍体和微缺失/微重复综合征方面的临床潜力
Mol Diagn Ther. 2023 Nov;27(6):769-779. doi: 10.1007/s40291-023-00674-x. Epub 2023 Sep 9.
6
Prenatal genetic diagnosis of monogenic diseases.单基因疾病的产前基因诊断
Adv Lab Med. 2023 Mar 24;4(1):28-51. doi: 10.1515/almed-2023-0024. eCollection 2023 Apr.
7
Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation.应用增强相对单体型剂量分析的无创性产前诊断单基因疾病。
PLoS One. 2023 Apr 24;18(4):e0280976. doi: 10.1371/journal.pone.0280976. eCollection 2023.
8
Accuracy of Non-Invasive Prenatal Testing for Duchenne Muscular Dystrophy in Families at Risk: A Systematic Review.对有风险家庭进行杜氏肌营养不良症无创产前检测的准确性:一项系统综述。
Diagnostics (Basel). 2023 Jan 4;13(2):183. doi: 10.3390/diagnostics13020183.
9
Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders.非侵入性产前诊断 (NIPD):游离于母体外周血中的胎儿 DNA 分析如何改变了单基因疾病的产前诊断。
Clin Sci (Lond). 2022 Nov 30;136(22):1615-1629. doi: 10.1042/CS20210380.
10
Next Generation Sequencing after Invasive Prenatal Testing in Fetuses with Congenital Malformations: Prenatal or Neonatal Investigation.先天性畸形胎儿有创性产前检测后的下一代测序:产前或新生儿调查。
Genes (Basel). 2022 Aug 24;13(9):1517. doi: 10.3390/genes13091517.
Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma.
基于单倍型的方法,利用孕妇血浆中的游离胎儿DNA进行杜氏肌营养不良症的无创产前检测。
Genet Med. 2015 Nov;17(11):889-96. doi: 10.1038/gim.2014.207. Epub 2015 Feb 5.
4
Non-invasive prenatal testing: a review of international implementation and challenges.非侵入性产前检测:国际实施情况和挑战综述。
Int J Womens Health. 2015 Jan 16;7:113-26. doi: 10.2147/IJWH.S67124. eCollection 2015.
5
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.基于大规模单核苷酸多态性的无创产前非整倍体检测的临床经验和随访。
Am J Obstet Gynecol. 2014 Nov;211(5):527.e1-527.e17. doi: 10.1016/j.ajog.2014.08.006. Epub 2014 Aug 8.
6
Non-invasive prenatal diagnosis: progress and potential.非侵入性产前诊断:进展与潜力
Arch Dis Child Fetal Neonatal Ed. 2014 Sep;99(5):F426-30. doi: 10.1136/archdischild-2013-304828. Epub 2014 Apr 30.
7
Haplotype-based approach for noninvasive prenatal diagnosis of congenital adrenal hyperplasia by maternal plasma DNA sequencing.基于单体型的母体外周血 DNA 测序在先天性肾上腺皮质增生症无创产前诊断中的应用。
Gene. 2014 Jul 10;544(2):252-8. doi: 10.1016/j.gene.2014.04.055. Epub 2014 Apr 24.
8
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.利用DNA大规模平行基因组测序技术对孕妇血液进行无创产前筛查,以检测胎儿21三体、18三体、13三体及常见性染色体非整倍体。
Am J Obstet Gynecol. 2014 Oct;211(4):365.e1-12. doi: 10.1016/j.ajog.2014.03.042. Epub 2014 Mar 19.
9
Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening.孕妇及其男性伴侣对无创产前检测和扩大产前筛查范围的态度。
Eur J Hum Genet. 2014 Dec;22(12):1345-50. doi: 10.1038/ejhg.2014.32. Epub 2014 Mar 19.
10
Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.利用母体血浆中游离胎儿DNA对先天性肾上腺皮质增生症进行无创产前诊断。
J Clin Endocrinol Metab. 2014 Jun;99(6):E1022-30. doi: 10.1210/jc.2014-1118. Epub 2014 Feb 28.